Literature DB >> 25814536

Speeding new antibiotics to market: a fake fix?

Peter Doshi.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25814536     DOI: 10.1136/bmj.h1453

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  New Kid on the Block Turns Ten! The Brief, Remarkable History of the National Physicians Alliance.

Authors:  Jean Silver-Isenstadt
Journal:  Perm J       Date:  2015

2.  Assessing Noninferiority in Treatment Trials for Severe Infectious Diseases: an Extension to the Entire Follow-Up Period Using a Cure-Death Multistate Model.

Authors:  Harriet Sommer; Tobias Bluhmki; Jan Beyersmann; Martin Schumacher
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Phage Therapies: Lessons (Not) Learned from the "Antibiotic Era".

Authors:  Carlos F Amábile-Cuevas
Journal:  Phage (New Rochelle)       Date:  2022-03-18

4.  How to measure the impacts of antibiotic resistance and antibiotic development on empiric therapy: new composite indices.

Authors:  Josie S Hughes; Amy Hurford; Rita L Finley; David M Patrick; Jianhong Wu; Andrew M Morris
Journal:  BMJ Open       Date:  2016-12-16       Impact factor: 2.692

5.  Why Antibiotic Use Data in Animals Needs to Be Collected and How This Can Be Facilitated.

Authors:  Jorge Pinto Ferreira
Journal:  Front Vet Sci       Date:  2017-12-12

Review 6.  Myths and Misconceptions around Antibiotic Resistance: Time to Get Rid of Them.

Authors:  Carlos F Amábile-Cuevas
Journal:  Infect Chemother       Date:  2022-08-05

7.  Noninferior Antibiotics: When Is "Not Bad" "Good Enough"?

Authors:  Mark J DiNubile
Journal:  Open Forum Infect Dis       Date:  2016-05-25       Impact factor: 3.835

Review 8.  Progress in the Fight Against Multidrug-Resistant Bacteria 2005-2016: Modern Noninferiority Trial Designs Enable Antibiotic Development in Advance of Epidemic Bacterial Resistance.

Authors:  John H Rex; George H Talbot; Mark J Goldberger; Barry I Eisenstein; Roger M Echols; John F Tomayko; Michael N Dudley; Aaron Dane
Journal:  Clin Infect Dis       Date:  2017-07-01       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.